Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05098405
Title First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Molecular Partners AG
Indications

skin squamous cell carcinoma

head and neck squamous cell carcinoma

prostate cancer

Advanced Solid Tumor

breast cancer

cervical cancer

colorectal cancer

bladder urothelial carcinoma

stomach cancer

endometrial cancer

lung non-small cell carcinoma

pancreatic cancer

malignant mesothelioma

anus cancer

ovarian cancer

melanoma

Therapies

MP0317

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.